Request Demo
Last update 30 Jul 2025
Neluxicapone
Last update 30 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ODM 104 |
Target |
Action inhibitors |
Mechanism COMT inhibitors(Catechol-O-methyl transferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC16H12N2O2 |
InChIKeyGILLLKMLIBNDKV-UHFFFAOYSA-N |
CAS Registry1498323-18-4 |
Related
7
Clinical Trials associated with NeluxicaponeNCT04571996
Blood-Brain Barrier Penetration of Therapeutic Agents in Human - an Exploratory Repeated Dose Pharmacokinetic Study in Patients With Idiopathic Normal Pressure Hydrocephalus Treated With Cerebroventricular Shunting
NCT03140956
Pharmacokinetics of Levodopa After Repeated Doses of Different Pellet Formulations; An Open, Randomized Study With Crossover Design in Healthy Male Subjects
NCT03055936
A Dose-finding Study for Levodopa, Carbidopa and ODM-104 Test Formulations After Repeated Administration in Healthy Males
100 Clinical Results associated with Neluxicapone
Login to view more data
100 Translational Medicine associated with Neluxicapone
Login to view more data
100 Patents (Medical) associated with Neluxicapone
Login to view more data
100 Deals associated with Neluxicapone
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Phase 2 | Finland | 08 Apr 2016 | |
| Parkinson Disease | Phase 2 | Germany | 08 Apr 2016 | |
| Parkinson Disease | Phase 2 | Hungary | 08 Apr 2016 | |
| Parkinson Disease | Phase 2 | Latvia | 08 Apr 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free